UPDATE 2-Drugmaker Shire bids $30 bln for Baxter spin-off Baxalta

LONDON, Aug 4 (Reuters) - Drugmaker Shire said on Tuesday it was seeking to buy Baxalta, a company spun-off by Baxter International last month, for $30 billion to forge the leading global specialist...